Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Doximity, Inc.

CIK 1516513 DOCS·Services · All EDGAR filings ↗

Progression

  1. Finance chief departure 8-K
  2. SEC comment letter CORRESP +28d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

SEC comment letter Filing comparison

Doximity, Inc. responded to SEC staff comments on MD&A

Letter dated 2026-03-23; published on EDGAR 2026-05-15 — the SEC releases comment letters only after the review closes.

We note from your disclosures on page 4 that your platform provides most medical professions with a pre-populated professional profile based on publicly and commercially available third-party data. Please show us how you intend to revise to clarify if the 80% figure includes only actively practicing physicians who have completed your identity and credential verification process or if some other criteria were used.…
Evidence
Direction
company to staff
Letter dated
2026-03-23
Published on edgar
2026-05-15
Reviewing
Doximity, Inc. Form 10-K for the Year Ended March 31, 2025 Form 10-Q for the Period Ended December 31, 2025 File No. 001-40508 Dear Ms. Etheredge and Mr. Little
Source
Company response to SEC staff (CORRESP)
Topics
MD&A, Revenue recognition
Why
SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.
SEC comment letter Filing comparison

SEC staff questioned Doximity, Inc.'s accounting for MD&A

Letter dated 2026-02-23; published on EDGAR 2026-05-15 — the SEC releases comment letters only after the review closes.

We note from your disclosures on page 4 that your platform provides most medical professions with a pre-populated professional profile based on publicly and commercially available third-party data. Please show us how you intend to revise to clarify if the 80% figure includes only actively practicing physicians who have completed your identity and credential verification process or if some other criteria were used.…
Evidence
Direction
staff to company
Letter dated
2026-02-23
Published on edgar
2026-05-15
Reviewing
Doximity, Inc. Form 10-K for the Year Ended March 31, 2025 Form 10-Q for the Period Ended December 31, 2025 File No. 001-40508 Dear Siddharth Sitaram: We have l
Source
SEC staff comment letter (UPLOAD)
Topics
MD&A
Why
SEC staff reviewed the company's periodic report and raised written comments on its accounting, or the company replied to them. Letters are published on EDGAR only after the review closes.
Finance chief departure elevated Filing comparison

Doximity, Inc.'s Chief Financial Officer departed, replaced on an interim basis

Evidence
Interim only
Yes
Item code
5.02
Item title
Departure of Directors or Certain Officers
Role
Chief Financial Officer
Severity
elevated
Source
SEC 8-K item code
Successor named
No
Why
The company's chief financial or accounting officer departed, disclosed under 8-K Item 5.02.